Osmotica Pharmaceuticals plc to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference
Osmotica Pharmaceuticals (Nasdaq: OSMT) announced that CEO Brian Markison and CFO Andrew Einhorn will present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference. The presentation is scheduled for May 19, 2021, at 4:50 p.m. Eastern Time. Interested participants can join the live webcast and access the archived presentation for 30 days via the company’s website. Osmotica focuses on developing specialty products for underserved patient markets and has operations in the U.S., Argentina, and Hungary.
- None.
- None.
BRIDGEWATER, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference as follows:
| Date: | Wednesday, May 19, 2021 |
| Time: | 4:50 p.m. Eastern Time |
| Webcast: | https://event.on24.com/wcc/r/3173544/97F2C4AFBDBA60F46E3A4A524A357E85 |
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.osmotica.com under the “Investor & News” section.
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting Upneeq®. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations. Osmotica has operations in the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
FAQ
When will Osmotica Pharmaceuticals present at the RBC Capital Markets Global Healthcare Conference?
What time is Osmotica's presentation at the conference?
Where can I watch Osmotica's presentation live?
How long will the archived presentation of Osmotica be available?
What is the focus of Osmotica Pharmaceuticals?
